6 results

• Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits

  November 17, 2025

  Irvin Jackson

  Following what it says are promising clinical trial results, Sanofi is seeking yet another approved use for Dupixent, even as concerns grow over the drug's potential link to T-cell lymphoma.

• Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations

  October 29, 2025

  Irvin Jackson

  Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.

• Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit

  October 17, 2025

  Irvin Jackson

  Parties involved in a Dupixent T-cell lymphoma wrongful death lawsuit will participate in an initial status conference in early December, to map out how the litigation will move forward.

• Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link

  October 8, 2025

  Russell Maas

  Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.

• Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis

  October 2, 2025

  Irvin Jackson

  A Dupixent lawsuit blames the atopic dermatitis drug for causing a woman to develop a deadly form of cancer, which caused her death.

• Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks

  September 4, 2025

  Russell Maas

  Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL).